Fulgent Genetics Inc — Balance Sheet (NASDAQ:FLGT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 700.46 M1.28 B1.39 B1.24 B1.22 B1.21 B Total liabilities 131.07 M112.84 M116.18 M102.04 M90.81 M106.81 M Total equity 569.39 M1.17 B1.27 B1.13 B1.13 B1.11 B Total liabilities & shareholders' equities 700.46 M1.28 B1.39 B1.24 B1.22 B1.21 B Total debt —————— Net debt ——————

News

Netflix, Dell among market cap stock movers on Friday

Netflix and Dell among market cap stock movers on Friday

Fulgent Q4 2025 slides: EPS beats, but customer loss drives stock plunge

Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates

Fulgent Genetics earnings beat by $0.22, revenue fell short of estimates

Brightspring Health Services, BASF, Swiss Re and more set to report Friday

Cheniere Energy to Report Q4 Earnings: What's in the Offing?

Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates

Fulgent Genetics (FLGT): The Price Has Caught Up To Value, But I Still Like The Stock

New Strong Buy Stocks for January 12th

FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform

Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million